0001161697-23-000300.txt : 20230517 0001161697-23-000300.hdr.sgml : 20230517 20230517170423 ACCESSION NUMBER: 0001161697-23-000300 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230515 FILED AS OF DATE: 20230517 DATE AS OF CHANGE: 20230517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCENANY PATRICK J CENTRAL INDEX KEY: 0000929985 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 23932680 MAIL ADDRESS: STREET 1: C/O THERMOGENESIS CORP STREET 2: 2711 CITRUS ROAD CITY: RANCHO CORDOVA STATE: CA ZIP: 95742 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form4.xml FORM 4 FOR 05-15-2023 X0407 4 2023-05-15 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0000929985 MCENANY PATRICK J 355 ALHAMBRA CIRCLE, SUITE 801 CORAL GABLES FL 33134 1 1 0 0 President and CEO 0 Common stock, par value $0.001 per share 2023-05-15 4 M 0 26151 0.79 A 3971587 D Common stock, par value $0.001 per share 2023-05-15 4 S 0 26151 13.23 D 3945436 D Common stock, par value $0.001 per share 2023-05-16 4 M 0 173849 0.79 A 4119285 D Options to purchase common stock 0.79 2023-05-15 4 M 0 26151 0 D 2023-06-15 Common Stock 26151 3101516 D Options to purchase common stock 0.79 2023-05-16 4 M 0 173849 0 D 2023-06-15 Common Stock 173849 2927667 D Shares were sold to cover tax withholding requirements. Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $13.20 to $13.285 per share. Options vested in two equal tranches beginning on June 15, 2017. /s/ Patrick J. McEnany 2023-05-17